Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer
- PMID: 23359763
- PMCID: PMC3555258
- DOI: 10.1007/s11670-012-0067-1
Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer
Abstract
Objective: To investigate the clinic values of combining test of serum matrix metalloproteinase 9 (MMP-9), acetyl heparinase (Hpa) and Cathepsin L (CL) in diagnosis of ovarian cancer.
Methods: Serum levels of MMP-9, Hpa and CL were detected in a total of 418 cases, including 217 cases with ovarian malignant tumor, 100 cases with ovarian benign tumor and 101 healthy controls, by using enzyme-linked immunosorbent assay (ELISA). Their correlation with clinicopathologic feature of ovarian malignant tumor was analyzed and their diagnosis performance was evaluated by receiver operating characteristic (ROC). The combined diagnosis model was established by logistic regression analysis.
Results: The serum levels of MMP-9, Hpa and CL were significantly higher in patients with ovarian malignant tumor than in benign tumor and healthy control, the serum levels of CL and Hpa were higher in epithelial cancer than in non-epithelial tumor, and MMP-9, Hpa and CL were elevated in low grade and advanced stage compared to high grade and early stage. The sensitivity for diagnosis of ovarian malignant tumor from high to low was CL, Hpa and MMP-9, and the specificity was MMP-9, CL and Hpa. The united diagnosis model was established and showed the sensitivity and specificity of combined detection were 84.6% and 82.1%, respectively, which were significantly higher than a single tumor marker.
Conclusion: Serum MMP-9, Hpa and CL were correlated with ovarian malignant tumor and the combined detection of which may be valuable for clinical diagnosis of ovarian malignant tumor.
Keywords: Acetyl heparinase; Cathepsin; Diagnosis; Matrix metalloproteinase 9; Ovarian cancer.
Figures
Similar articles
-
Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.Anticancer Res. 2011 Oct;31(10):3423-8. Anticancer Res. 2011. PMID: 21965756
-
[The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):931-6. Zhonghua Fu Chan Ke Za Zhi. 2008. PMID: 19134334 Chinese.
-
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.Anticancer Res. 2007 Jul-Aug;27(4C):2753-8. Anticancer Res. 2007. PMID: 17695443
-
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].Ai Zheng. 2004 Oct;23(10):1194-8. Ai Zheng. 2004. PMID: 15473934 Chinese.
-
Role of heparinase in the gastrointestinal dysfunction of sepsis (Review).Exp Ther Med. 2022 Feb;23(2):119. doi: 10.3892/etm.2021.11042. Epub 2021 Dec 6. Exp Ther Med. 2022. PMID: 34970342 Free PMC article. Review.
Cited by
-
Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer.Transl Oncol. 2018 Dec;11(6):1292-1300. doi: 10.1016/j.tranon.2018.08.003. Epub 2018 Aug 30. Transl Oncol. 2018. PMID: 30172882 Free PMC article.
-
DHA- and EPA-Enriched Phosphatidylcholine Suppress Human Lung Carcinoma 95D Cells Metastasis via Activating the Peroxisome Proliferator-Activated Receptor γ.Nutrients. 2022 Nov 4;14(21):4675. doi: 10.3390/nu14214675. Nutrients. 2022. PMID: 36364935 Free PMC article.
References
-
- Shaaban A, Rezvani M.Ovarian cancer: detection and radiologic staging. Clin Obstet Gynecol 2009;52:73-93 - PubMed
-
- Wang SM, Li L, Zhang W, et al. Clinical value of detection of serum cathepsin L on diagnosis of ovarian cancer. Zhong Guo Zhong Liu Lin Chuang (in Chinese)2008;35:167-8
-
- Zhou J, Li L, Wang SM, et al. Elevated Serum Level of MMP-9 in malignant ovarian tumor and its clinical significance. Shi Yong Fu Chan Ke Za Zhi (in Chinese)2008;24:346-9
LinkOut - more resources
Full Text Sources
Miscellaneous